(Q33390098)

English

Phase II trial of short-course R-CHOP followed by 90Y-ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patients

scientific article

Statements

Phase II trial of short-course R-CHOP followed by 90Y-ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patients (English)
Silvia Franceschetti
Maria Giuseppina Cabras
Maria Concetta Petti

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit